GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Percheron Therapeutics Ltd (OTCPK:PERCF) » Definitions » Issuance of Stock

PERCF (Percheron Therapeutics) Issuance of Stock : $7.77 Mil (TTM As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Percheron Therapeutics Issuance of Stock?

Percheron Therapeutics's Issuance of Stock for the six months ended in Dec. 2023 was $7.77 Mil.

Percheron Therapeutics's Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2023 was $7.77 Mil.

Percheron Therapeutics Issuance of Stock Historical Data

The historical data trend for Percheron Therapeutics's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Percheron Therapeutics Issuance of Stock Chart

Percheron Therapeutics Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Issuance of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.79 6.50 15.87 - 7.71

Percheron Therapeutics Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 7.77 -

Percheron Therapeutics Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $7.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Percheron Therapeutics Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Percheron Therapeutics's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Percheron Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Percheron Therapeutics Ltd (OTCPK:PERCF) » Definitions » Issuance of Stock
Comparable Companies
ASX:SNT ASX:VIT ASX:MVP ASX:IDT ASX:NXS ASX:LGP ASX:VLS ASX:CAN ASX:ECS ASX:EOF ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB VTRS
Traded in Other Exchanges
AWY0:Germany AWY0:Germany PER:Australia
Address
14 Wallace Avenue, LEVEL 1, Toorak, VIC, AUS, 3142
Website
https://www.percherontx.com
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.